TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16393429

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg
Number of subjects: 2848

Group type: EXPERIMENTAL
Intervention: Solifenacin 10 mg
Number of subjects: 2848

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2848
Study: 14512191

Group type: EXPERIMENTAL
Intervention: RT arm
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: CRT arm
Number of subjects: 488
Study: 10838648

Group type: EXPERIMENTAL
Intervention: PATCH model intervention (n=310)
Number of subjects: 945

Group type: COMPARATOR
Intervention: Usual care (n=310)
Number of subjects: 945
Study: 9357149

Group type: EXPERIMENTAL
Intervention: ILD patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 20
Study: 8222677

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 3108064

Group type: EXPERIMENTAL
Intervention: Indomethacin (200 mg) administered 15 and 2 hours before testing
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30127051

Group type: EXPERIMENTAL
Intervention: mHealth and community mobilisation interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Status quo (control group)
Number of subjects: 0
Study: 25209524

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) provided at discharge
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Participants who requested NRT at discharge
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Participants with more severe psychiatric symptoms
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Older participants
Number of subjects: 816
Study: 24708748

Group type: EXPERIMENTAL
Intervention: Drug-negative patients (84% opioids, 76% stimulants, 62% alcohol, 33% marijuana)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Drug-positive patients
Number of subjects: 494
Study: 23594592

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18201

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18201
Study: 21169896

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-10 mg daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sertraline (50-100 mg daily)
Number of subjects: 120
Study: 18420877

Group type: EXPERIMENTAL
Intervention: Epidural (0.375% ropivacaine)/general anesthesia (group R)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Epidural (saline)/general anesthesia (group C)
Number of subjects: 32
Study: 17035872

Group type: EXPERIMENTAL
Intervention: iopamidol-370 (370 mgI/mL)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: iodixanol-320 (320 mgI/mL)
Number of subjects: 166
Study: 14671423

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Balloon treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham treatment followed by balloon treatment
Number of subjects: 32
Study: 10696316

Group type: EXPERIMENTAL
Intervention: Anaesthetic infiltration into the sub‐Tenon's space through a conjunctival incision (115 eyes)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Infiltration into the posterior sub‐Tenon's space (retrobulbar space) through a conjunctival incision (114 eyes)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Injection into the intra‐Tenon's space (subconjunctival space) without making a conjunctival incision (116 eyes)
Number of subjects: 345
Study: 8540712

Group type: EXPERIMENTAL
Intervention: Cefodizime 0.5 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefodizime 1.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefodizime 2.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefodizime 3.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefodizime (all doses)
Number of subjects: 0
Study: 1902327

Group type: EXPERIMENTAL
Intervention: Enprostil, a PGE2 derivative, at a dose of 35 micrograms bid
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6794746

Group type: EXPERIMENTAL
Intervention: Intraperitoneal insulin injection (20 U of regular insulin) into an empty peritoneal cavity
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intraperitoneal insulin injection (20 U of regular insulin) followed by 2 litres of 1.5% dextrose dialysate
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intraperitoneal insulin injection (20 U of regular insulin) followed by 2 litres of 4.5% dextrose dialysate
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intraperitoneal insulin injection (20 U of regular insulin) followed by 20 ml of saline
Number of subjects: 9
Study: 28982501

Group type: EXPERIMENTAL
Intervention: PA pressure-guided management
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: PA pressure-guided management in patients tolerating GDMT
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: PA pressure-guided management in patients receiving both components of optimal GDMT
Number of subjects: 456
Study: 25644760

Group type: EXPERIMENTAL
Intervention: Terlipressin plus albumin (TERLI group)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Midodrine and octreotide plus albumin (MID/OCT group)
Number of subjects: 49
Study: 23426978

Group type: EXPERIMENTAL
Intervention: everolimus 10 mg/day
Number of subjects: 25
Study: 20656527

Group type: EXPERIMENTAL
Intervention: Extraoral alar base cinch suture
Number of subjects: 35

Group type: COMPARATOR
Intervention: Classic intraoral suture
Number of subjects: 35
Study: 19413826

Group type: EXPERIMENTAL
Intervention: Classic Laryngeal Mask Airway (cLMA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask Airway (ILMA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Combitube (CT)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Tracheal Intubation (TI)
Number of subjects: 5
Study: 18062848

Group type: EXPERIMENTAL
Intervention: Attitude-congruent in-group norm in high uncertainty condition
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Attitude-incongruent in-group norm in high uncertainty condition
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Ambiguous in-group norm in high uncertainty condition
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Attitude-congruent in-group norm in low uncertainty condition
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Attitude-incongruent in-group norm in low uncertainty condition
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Ambiguous in-group norm in low uncertainty condition
Number of subjects: 189
Study: 16170894

Group type: EXPERIMENTAL
Intervention: (166) HO-DOTMP plus melphalan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Melphalan alone
Number of subjects: 0
Study: 11717214

Group type: EXPERIMENTAL
Intervention: Intravenous propofol anesthesia (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Inhalational anesthesia with desflurane (n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both anesthesia types (propofol and desflurane)
Number of subjects: 12
Study: 9159421

Group type: EXPERIMENTAL
Intervention: Assessment of gynaecological disorders including measurement of hormone concentrations, cervical cytology, and pelvic ultrasound scan.
Number of subjects: 100
Study: 8241913

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 1806

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1806
Study: 3662591

Group type: EXPERIMENTAL
Intervention: Green light phototherapy (350‐650 nm)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Blue light phototherapy (300‐600 nm)
Number of subjects: 262
Study: 29641671

Group type: EXPERIMENTAL
Intervention: Local incision analgesia (LIA) with ropivacaine and postoperative analgesia pump
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local incision analgesia (LIA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (PCA) with fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with tramadol hydrochloride injection
Number of subjects: 60
Study: 26769742

Group type: COMPARATOR
Intervention: Information-only SMS text messages
Number of subjects: 1372

Group type: COMPARATOR
Intervention: Interactive SMS text messages
Number of subjects: 1372

Group type: EXPERIMENTAL
Intervention: Usual care
Number of subjects: 1372
Study: 25605477

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA-PPQ)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Dispersible artemether-lumefantrine (AL)
Number of subjects: 218
Study: 24221391

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TAVR
Number of subjects: 0

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 0
Study: 21178977

Group type: EXPERIMENTAL
Intervention: Cyclosporine (12-month regimen)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Mycophenolate mofetil and oral dexamethasone (12-month regimen)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Quality of life measurement
Number of subjects: 138
Study: 18694917

Group type: EXPERIMENTAL
Intervention: Wrist-bridging external fixation with alternating electric current stimulation (EF + ES)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Wrist-bridging external fixation without alternating electric current stimulation (EF)
Number of subjects: 2
Study: 16569807

Group type: EXPERIMENTAL
Intervention: Verapamil sustained-release (SR) hypertension treatment
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Atenolol-based hypertension treatment
Number of subjects: 1152
Study: 12818266

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily for up to 12 months
Number of subjects: 1326

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40, 20, or 10 mg daily for up to 6 months
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1326
Study: 10393140

Group type: EXPERIMENTAL
Intervention: Synthesized triacylglycerol formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 0
Study: 8992517

Group type: EXPERIMENTAL
Intervention: Flupentixol (exact dosage and duration not specified)
Number of subjects: 62
Study: 1854052

Group type: EXPERIMENTAL
Intervention: Polyethylene catheter (Leader Cath. 115‐09)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Teflon catheter (Plastimed Seldicath)
Number of subjects: 101
Study: 6362698

Group type: EXPERIMENTAL
Intervention: Brotizolam (0.25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (2.0 mg)
Number of subjects: 0
Study: 30804065

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum magnesium concentrations (increase of 0.1 mmol/L)
Number of subjects: 404847

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum calcium concentrations (increase of 0.5 mg/dL)
Number of subjects: 404847
Study: 28406384

Group type: EXPERIMENTAL
Intervention: Cabergoline (D2 dopamine agonist)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 27030543

Group type: EXPERIMENTAL
Intervention: Gly-Pro-Ile-Gly-Ser (GPIGS) penta-peptide
Number of subjects: 22
Study: 25009138

Group type: EXPERIMENTAL
Intervention: New-look EpiPen
Number of subjects: 271

Group type: COMPARATOR
Intervention: Original EpiPen
Number of subjects: 271

Group type: COMPARATOR
Intervention: Anapen
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 271
Study: 23177300

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent implantation
Number of subjects: 30
Study: 20926970

Group type: EXPERIMENTAL
Intervention: Swaddled and held in an upright position during heel lance (experimental group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care position (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Swaddled (experimental group)
Number of subjects: 42
Study: 18591543

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant interleukin-2 (rIL-2) maintenance immunotherapy for 90 days, consisting of 14-day cycles followed by 3-day higher doses.
Number of subjects: 254

Group type: COMPARATOR
Intervention: No further therapy (control group)
Number of subjects: 254
Study: 15842212

Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/die)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (17-beta-estradiol 1 mg plus norethisterone acetate 0.5 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 12433766

Group type: EXPERIMENTAL
Intervention: Structured screening test
Number of subjects: 582

Group type: COMPARATOR
Intervention: Parent led method
Number of subjects: 582
Study: 9843011

Group type: EXPERIMENTAL
Intervention: Topical clindamycin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Systemic tetracycline
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patients' global assessment
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Correlation between assessments
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Soreness
Number of subjects: 46
Study: 7640501

Group type: EXPERIMENTAL
Intervention: Fungus Lipid‐reducing Capsule (FLC) treated group
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Augmented treated group
Number of subjects: 230
Study: 2569191

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg in soft gelatine capsule
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg in uncoated tablet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 12
Study: 786682

Group type: EXPERIMENTAL
Intervention: Pentaerythritol trinitrate (PETRIN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 28755481

Group type: EXPERIMENTAL
Intervention: Immediate mobilization group (n = 45)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 4-hour bed rest group (n = 40)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 6-hour bed rest group (n = 34)
Number of subjects: 119
Study: 26879051

Group type: EXPERIMENTAL
Intervention: In-person CBT for ten weeks
Number of subjects: 230

Group type: COMPARATOR
Intervention: IVR-based CBT for ten weeks
Number of subjects: 230
Study: 24721597

Group type: EXPERIMENTAL
Intervention: Lateral closing wedge technique
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Combined wedge osteotomy technique
Number of subjects: 110
Study: 23893227

Group type: EXPERIMENTAL
Intervention: Maternal sexuality education program (Experimental group)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (received program after the experiment)
Number of subjects: 55
Study: 20637332

Group type: EXPERIMENTAL
Intervention: Limberg flap procedure
Number of subjects: 260

Group type: COMPARATOR
Intervention: Primary closure
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Limberg flap
Number of subjects: 260
Study: 18400704

Group type: EXPERIMENTAL
Intervention: Whole-grain diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Refined-cereal-grain diet
Number of subjects: 30
Study: 16783046

Group type: EXPERIMENTAL
Intervention: Praneem polyherbal vaginal tablet used intravaginally once daily for 14 consecutive days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Praneem polyherbal vaginal tablet
Number of subjects: 20
Study: 14512000

Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg daily)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 11716075

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide/methylcellulose paste (group A)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Camphorated parachlorophenol/calcium hydroxide paste (group B)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine/methylcellulose gel (group C)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide points (group D)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Positive control (no medication)
Number of subjects: 15
Study: 9384018

Group type: EXPERIMENTAL
Intervention: Victorian Order of Nurses (VON) services in the home
Number of subjects: 163
Study: 7942832

Group type: EXPERIMENTAL
Intervention: Low volume digital subtraction renal angiography with low osmolar contrast media
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diagnostic renal angiography and angioplasty
Number of subjects: 0
Study: 3149082

Group type: EXPERIMENTAL
Intervention: Rioprostil 600 micrograms
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Rioprostil 300 micrograms
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 2291751

Group type: EXPERIMENTAL
Intervention: Sodium naproxen 550 mg every 12 h
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium diclofenac 100 mg every 12 h
Number of subjects: 100
Study: 1256106

Group type: EXPERIMENTAL
Intervention: Nurse practitioner care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular clinic (control)
Number of subjects: 0
Study: 31101682

Group type: EXPERIMENTAL
Intervention: ranolazine
Number of subjects: 24

Group type: COMPARATOR
Intervention: best standard therapy (BST)
Number of subjects: 24
Study: 28383414

Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine cream (5% lidocaine and 25 mg/g prilocaine, 5g applied preoperatively)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (lidocaine gel used for lubrication of urinary catheter)
Number of subjects: 146
Study: 26129630

Group type: EXPERIMENTAL
Intervention: 5AsT intervention tools
Number of subjects: 29
Study: 23590257

Group type: EXPERIMENTAL
Intervention: Task-oriented intervention focused on timing and coordination of gait (TC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Conventional gait intervention focusing on walking, endurance, balance, and strength (WEBS)
Number of subjects: 44
Study: 21481862

Group type: EXPERIMENTAL
Intervention: Magnetic endoscopic imaging (MEI)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Standard colonoscopy with on-demand fluoroscopy
Number of subjects: 810
Study: 19056445

Group type: EXPERIMENTAL
Intervention: Telephone recall system managed by pediatricians not previously involved in care (group 1)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Telephone recall system managed by pediatricians from asthma clinic (group 2)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Telephone recall system managed by pediatricians from asthma clinic with vaccine administered in the same clinic (group 3)
Number of subjects: 285
Study: 17197590

Group type: EXPERIMENTAL
Intervention: Breastfeeding educational material and individual coaching from a lactation counselor
Number of subjects: 401

Group type: COMPARATOR
Intervention: Breastfeeding educational material with no counseling
Number of subjects: 401

Group type: COMPARATOR
Intervention: Routine antenatal care only
Number of subjects: 401
Study: 15077287

Group type: EXPERIMENTAL
Intervention: Infliximab plus MTX
Number of subjects: 428

Group type: COMPARATOR
Intervention: MTX-only
Number of subjects: 428
Study: 11408210

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 5 mg/kg daily
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 5 mg/kg daily and rifampin (RIF) 10 mg/kg daily
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 5 mg/kg daily plus 10 mg of rifalazil once weekly
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 5 mg/kg daily and 25 mg of rifalazil once weekly
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study: 9495409

Group type: EXPERIMENTAL
Intervention: 0.1 mg intrathecal morphine plus 75 mg i.m. diclofenac every 8 h
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.05 mg intrathecal morphine plus 75 mg i.m. diclofenac every 8 h
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.025 mg intrathecal morphine plus 75 mg i.m. diclofenac every 8 h
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.1 mg intrathecal morphine plus i.m. diclofenac on demand
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.05 mg intrathecal morphine plus i.m. diclofenac on demand
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.025 mg intrathecal morphine plus i.m. diclofenac on demand
Number of subjects: 120
Study: 7850234

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: No haloperidol
Number of subjects: 0
Study: 3053587

Group type: EXPERIMENTAL
Intervention: Carbohydrate feeding (1 g/kg at 10 min, then 0.6 g/kg every 30 min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sweet placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Carbohydrate feeding
Number of subjects: 7
Study: 31902925

Group type: EXPERIMENTAL
Intervention: DT algorithm for initial dose settings of VCM
Number of subjects: 654

Group type: COMPARATOR
Intervention: Conventional dose-setting methods
Number of subjects: 654
Study: 30981162

Group type: EXPERIMENTAL
Intervention: Guided internet-based cognitive behavioural therapy (ICBT)
Number of subjects: 120
Study: 28287490

Group type: EXPERIMENTAL
Intervention: Vitamin B12-containing multiple micronutrient supplement
Number of subjects: 193

Group type: COMPARATOR
Intervention: Unsupplemented
Number of subjects: 193
Study: 25763531

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (300 to 1800 IU per day)
Number of subjects: 961

Group type: COMPARATOR
Intervention: Vitamin D supplementation
Number of subjects: 961
Study: 23484542

Group type: EXPERIMENTAL
Intervention: Curd consumption
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-consuming curd
Number of subjects: 40
Study: 21984924

Group type: EXPERIMENTAL
Intervention: gp140 vaccine (100 µg in 3 ml of Carbopol 974P based gel)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo solution in Carbopol gel
Number of subjects: 22
Study: 18224343

Group type: EXPERIMENTAL
Intervention: Mizoribine combination therapy
Number of subjects: 23
Study: 16388436

Group type: EXPERIMENTAL
Intervention: Dietary restriction (Group A) - self-determined weight loss of approximately 5% body weight, energy restriction of -4 MJ per day.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (Group B) - maintained body weight during the week before the competition.
Number of subjects: 20